These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31642607)

  • 1. Lack of Detection of the Analgesic Properties of PF-05089771, a Selective Na
    Siebenga P; van Amerongen G; Hay JL; McDonnell A; Gorman D; Butt R; Groeneveld GJ
    Clin Transl Sci; 2020 Mar; 13(2):318-324. PubMed ID: 31642607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain models.
    Loudon P; Siebenga P; Gorman D; Gore K; Dua P; van Amerongen G; Hay JL; Groeneveld GJ; Butt RP
    Br J Clin Pharmacol; 2018 Feb; 84(2):301-309. PubMed ID: 29178434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs.
    Siebenga PS; van Amerongen G; Okkerse P; Denney WS; Dua P; Butt RP; Hay JL; Groeneveld GJ
    Eur J Pain; 2019 Jul; 23(6):1129-1140. PubMed ID: 30793411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover study.
    Okkerse P; van Amerongen G; de Kam ML; Stevens J; Butt RP; Gurrell R; Dahan A; van Gerven JM; Hay JL; Groeneveld GJ
    Br J Clin Pharmacol; 2017 May; 83(5):976-990. PubMed ID: 27862179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy.
    McDonnell A; Collins S; Ali Z; Iavarone L; Surujbally R; Kirby S; Butt RP
    Pain; 2018 Aug; 159(8):1465-1476. PubMed ID: 29578944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 Channels.
    Theile JW; Fuller MD; Chapman ML
    Mol Pharmacol; 2016 Nov; 90(5):540-548. PubMed ID: 27587537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral and somatic pain modalities reveal Na
    Hockley JR; González-Cano R; McMurray S; Tejada-Giraldez MA; McGuire C; Torres A; Wilbrey AL; Cibert-Goton V; Nieto FR; Pitcher T; Knowles CH; Baeyens JM; Wood JN; Winchester WJ; Bulmer DC; Cendán CM; McMurray G
    J Physiol; 2017 Apr; 595(8):2661-2679. PubMed ID: 28105664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels.
    Jones HM; Butt RP; Webster RW; Gurrell I; Dzygiel P; Flanagan N; Fraier D; Hay T; Iavarone LE; Luckwell J; Pearce H; Phipps A; Segelbacher J; Speed B; Beaumont K
    Clin Pharmacokinet; 2016 Jul; 55(7):875-887. PubMed ID: 26895021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase I, Randomized, Double-Blind, Laser-Evoked Potential Study to Evaluate the Analgesic/Antihyperalgesic Effect of ASP9226, a State-Dependent N-Type Voltage-Gated Calcium Channel Inhibitor, in Healthy Male Subjects.
    Schaffler K; He W; Passier P; Tracy K; Fakhoury A; Paul J
    Pain Med; 2018 Nov; 19(11):2246-2255. PubMed ID: 29378016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic efficacy of tramadol, pregabalin and ibuprofen in menthol-evoked cold hyperalgesia.
    Altis K; Schmidtko A; Angioni C; Kuczka K; Schmidt H; Geisslinger G; Lötsch J; Tegeder I
    Pain; 2009 Dec; 147(1-3):116-21. PubMed ID: 19762153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the predictive validity of laser-EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers.
    Schaffler K; Nicolas LB; Borta A; Brand T; Reitmeir P; Roebling R; Scholpp J
    Br J Clin Pharmacol; 2017 Jul; 83(7):1424-1435. PubMed ID: 28139023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test battery.
    Okkerse P; Alvarez-Jimenez R; Hay JL; Tehim A; Kumar R; de Kam ML; Groeneveld GJ
    Eur J Pain; 2017 Mar; 21(3):494-506. PubMed ID: 27651026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABA
    van Amerongen G; Siebenga PS; Gurrell R; Dua P; Whitlock M; Gorman D; Okkerse P; Hay JL; Butt RP; Groeneveld GJ
    Br J Anaesth; 2019 Aug; 123(2):e194-e203. PubMed ID: 30915991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar excitability through different sodium channels and implications for the analgesic efficacy of selective drugs.
    Xie YF; Yang J; Ratté S; Prescott SA
    Elife; 2024 Apr; 12():. PubMed ID: 38687187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-shifted co-administration of sub-analgesic doses of ambroxol and pregabalin attenuates oxaliplatin-induced cold allodynia in mice.
    Furgała A; Fijałkowski Ł; Nowaczyk A; Sałat R; Sałat K
    Biomed Pharmacother; 2018 Oct; 106():930-940. PubMed ID: 30119265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core.
    Wang JT; Zheng YM; Chen YT; Gu M; Gao ZB; Nan FJ
    Acta Pharmacol Sin; 2020 Mar; 41(3):293-302. PubMed ID: 31316182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the T-Type Calcium Channel Blocker ABT-639 in an Intradermal Capsaicin Experimental Pain Model in Healthy Adults.
    Wallace M; Duan R; Liu W; Locke C; Nothaft W
    Pain Med; 2016 Mar; 17(3):551-560. PubMed ID: 26814294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG).
    Mouraux A; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Di Stefano G; Finnerup NB; Garcia-Larrea L; Goetz M; Kostenko A; Pelz B; Pogatzki-Zahn E; Schubart K; Stouffs A; Truini A; Tracey I; Troconiz IF; Van Niel J; Vela JM; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Phillips KG; Treede RD
    Trials; 2021 Jun; 22(1):404. PubMed ID: 34140041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity.
    Leone C; Di Stefano G; Di Pietro G; Bloms-Funke P; Boesl I; Caspani O; Chapman SC; Finnerup NB; Garcia-Larrea L; Li T; Goetz M; Mouraux A; Pelz B; Pogatzki-Zahn E; Schilder A; Schnetter E; Schubart K; Tracey I; Troconiz IF; Van Niel H; Hernandez JMV; Vincent K; Vollert J; Wanigasekera V; Wittayer M; Phillips KG; Truini A; Treede RD
    Trials; 2022 Sep; 23(1):739. PubMed ID: 36064434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of a single methyl group to a small molecule sodium channel inhibitor introduces a new mode of gating modulation.
    Wang L; Zellmer SG; Printzenhoff DM; Castle NA
    Br J Pharmacol; 2015 Oct; 172(20):4905-18. PubMed ID: 26220736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.